Among 3 analysts covering Nielsen Holdings (NYSE:NLSN), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Nielsen Holdings had 6 analyst reports since October 29, 2018 according to SRatingsIntel. The firm has “Hold” rating by Credit Suisse given on Friday, March 1. The stock of Nielsen Holdings plc (NYSE:NLSN) earned “Market Perform” rating by BMO Capital Markets on Monday, March 4. The rating was maintained by SunTrust with “Buy” on Thursday, March 7. SunTrust maintained Nielsen Holdings plc (NYSE:NLSN) rating on Monday, October 29. SunTrust has “Buy” rating and $27 target. See Nielsen Holdings plc (NYSE:NLSN) latest ratings:
09/03/2019 Broker: BidaskScore Rating: Hold Upgrade
07/03/2019 Broker: SunTrust Rating: Buy New Target: $28 Maintain
04/03/2019 Broker: BMO Capital Markets Old Rating: Market Perform New Rating: Market Perform Old Target: $24 New Target: $26 Maintain
01/03/2019 Broker: Credit Suisse Rating: Hold New Target: $27 Maintain
07/12/2018 Broker: Credit Suisse Rating: Neutral New Target: $29 Initiates Coverage On
29/10/2018 Broker: SunTrust Old Rating: Buy New Rating: Buy Old Target: $28 New Target: $27 Maintain
Analysts expect InflaRx N.V. (NASDAQ:IFRX) to report $-0.44 EPS on April, 4.After having $-0.31 EPS previously, InflaRx N.V.’s analysts see 41.94% EPS growth. The stock decreased 3.66% or $1.66 during the last trading session, reaching $43.69. About 97,463 shares traded. InflaRx N.V. (NASDAQ:IFRX) has risen 39.39% since March 24, 2018 and is uptrending. It has outperformed by 35.02% the S&P500. Some Historical IFRX News: 08/05/2018 – InflaRx N.V. Announces Closing of Primary and Secondary Offering of Common Shrs; 29/03/2018 – InflaRx Full Year 2017 Financial & Operating Results; 17/05/2018 – InflaRx 1Q Loss EUR10.3M; 17/05/2018 – INFLARX NV – CASH POSITION APPROXIMATELY US$137 MLN (EUR 115 MLN) AS OF MARCH 31, 2018; 17/05/2018 – InflaRx 1Q Loss/Shr EUR0.04; 08/03/2018 – INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE llB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA; 29/03/2018 – InflaRx FY Loss/Shr EUR2.6; 08/03/2018 – lnflaRx announces first patient enrolled in Phase llb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 08/03/2018 InflaRx announces first patient enrolled in Phase IIb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 03/05/2018 – INFLARX PRIMARY, SECONDARY OFFERINGS PRICES AT $34.00 PER SHARE
InflaRx N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology primarily in the United States and Europe. The company has market cap of $1.12 billion. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The company’s lead product candidate is IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that is in the Phase IIb clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of other chronic/autoimmune diseases.
More notable recent InflaRx N.V. (NASDAQ:IFRX) news were published by: Nasdaq.com which released: “Why Investors Shouldn’t Sweat Tencent Music’s Post-Earnings Drop – Nasdaq” on March 23, 2019, also Nasdaq.com with their article: “BRP Reports Fourth Quarter and Fiscal Year 2019 Results – Nasdaq” published on March 22, 2019, Nasdaq.com published: “Just Energy Advances Strategic Transformation with Cost Reduction Initiative – Nasdaq” on March 21, 2019. More interesting news about InflaRx N.V. (NASDAQ:IFRX) were released by: Streetinsider.com and their article: “InflaRx NV (IFRX) Granted Approval to Begin Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum – StreetInsider.com” published on February 27, 2019 as well as Nasdaq.com‘s news article titled: “AC Immune Reports Full-Year 2018 Financial Results and Provides Business Update – Nasdaq” with publication date: March 21, 2019.
More notable recent Nielsen Holdings plc (NYSE:NLSN) news were published by: Benzinga.com which released: “Nielsen Enters The Cannabis Industry (NYSE:NLSN) – Benzinga” on March 06, 2019, also Seekingalpha.com with their article: “Nielsen Q4 2018 Earnings Preview – Seeking Alpha” published on February 27, 2019, Seekingalpha.com published: “Nielsen Holdings N.V. (NLSN) CEO David Kenny on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” on February 28, 2019. More interesting news about Nielsen Holdings plc (NYSE:NLSN) were released by: Investorplace.com and their article: “10 Stocks on the Rise Heading Into the Second Quarter – Investorplace.com” published on March 20, 2019 as well as Streetinsider.com‘s news article titled: “Nielsen Holdings (NLSN) Announces Long-term Agreement with Univision Communications Inc. for National and Local TV Ratings Measurement – StreetInsider.com” with publication date: March 21, 2019.
The stock decreased 2.04% or $0.56 during the last trading session, reaching $26.86. About 2.03M shares traded. Nielsen Holdings plc (NYSE:NLSN) has declined 15.85% since March 24, 2018 and is downtrending. It has underperformed by 20.22% the S&P500. Some Historical NLSN News: 14/05/2018 – CBS And Nielsen Collaborate To Advance Dynamic Ad lnsertion In Live Broadcasts; 26/04/2018 – Homeland Secur: Secretary Kirstjen M. Nielsen Announcement on Temporary Protected Status for Nepal; 12/04/2018 – STOLT-NIELSEN LTD: THE COMPANY INTENDS TO RESUME ITS BUY-BACK PROGRAMME ON APRIL 16, 2018, FOLLOWING THE RELEASE OF ITS FIRST-QUARTER EARNINGS; 05/04/2018 – Nielsen Launches Next-Generation Viewership Analytics Platform Covering Top 56 U.S. TV Markets; 18/04/2018 – Nielsen Study Confirms Airport Advertising Drives Sales for National & Local Brands, Significantly Increasing Web and Foot Traffic and Spurring Consumers to Act; 16/04/2018 – UK’S CMA – CONSIDERING WHETHER NIELSEN- EBIQUITY DEAL MAY RESULT IN SUBSTANTIAL LESSENING OF COMPETITION WITHIN ANY MARKET OR MARKETS IN THE UK; 08/03/2018 – OGE: Nielsen, Kirstjen – Department Of Homeland Security; 13/04/2018 – NIELSEN HOLDINGS – CO, DEL MONTE FOODS ANNOUNCE EXPANSION OF A MULTI-YEAR RELATIONSHIP; 19/04/2018 – NIELSEN BOOSTS QTRLY DIV TO 35C/SHR FROM 34C, BDVD EST. 37C; 19/04/2018 – Nielsen Holdings Raises Dividend to 35c
Nielsen Holdings plc operates as an information and measurement company. The company has market cap of $9.55 billion. It operates through two divisions, Buy and Watch. It currently has negative earnings. The firm provides media and marketing information, analytics, and maker and retailer expertise about what and where clients buy, read, watch, and listen.